Ascendis Pharma A/S (BSP:A1SN34) Current Accrued Expense : R$0 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Ascendis Pharma A/S Current Accrued Expense?

Ascendis Pharma A/S's Current Accrued Expense for the quarter that ended in Mar. 2024 was R$0 Mil.

Ascendis Pharma A/S Current Accrued Expense Historical Data

The historical data trend for Ascendis Pharma A/S's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma A/S Current Accrued Expense Chart

Ascendis Pharma A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

Ascendis Pharma A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Ascendis Pharma A/S Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Ascendis Pharma A/S Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma A/S's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Pharma A/S (BSP:A1SN34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma A/S (BSP:A1SN34) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

ASND:USA ASND:Mexico A71:Germany

Address

Tuborg Boulevard 12, Hellerup, DNK, DK-2900

Website

http://www.ascendispharma.com

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.

Ascendis Pharma A/S (BSP:A1SN34) Headlines

No Headlines